CEGEDIM SA (ALCGM.PA) Fundamental Analysis & Valuation

EPA:ALCGM • FR0000053506

Current stock price

13.7 EUR
+0.45 (+3.4%)
Last:

This ALCGM.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALCGM.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALCGM was profitable.
  • ALCGM had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ALCGM reported negative net income in multiple years.
  • Each year in the past 5 years ALCGM had a positive operating cash flow.
ALCGM.PA Yearly Net Income VS EBIT VS OCF VS FCFALCGM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

1.2 Ratios

  • The Return On Assets of ALCGM (0.93%) is comparable to the rest of the industry.
  • ALCGM has a Return On Equity of 3.33%. This is comparable to the rest of the industry: ALCGM outperforms 54.55% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.23%, ALCGM is in line with its industry, outperforming 54.55% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ALCGM is below the industry average of 7.85%.
  • The last Return On Invested Capital (4.23%) for ALCGM is above the 3 year average (3.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.93%
ROE 3.33%
ROIC 4.23%
ROA(3y)-0.45%
ROA(5y)0.69%
ROE(3y)-1.64%
ROE(5y)2.23%
ROIC(3y)3.75%
ROIC(5y)3.59%
ALCGM.PA Yearly ROA, ROE, ROICALCGM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.45%, ALCGM is in line with its industry, outperforming 54.55% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ALCGM has declined.
  • Looking at the Operating Margin, with a value of 5.64%, ALCGM is in line with its industry, outperforming 54.55% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ALCGM has declined.
  • The Gross Margin of ALCGM (20.78%) is worse than 81.82% of its industry peers.
  • ALCGM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.64%
PM (TTM) 1.45%
GM 20.78%
OM growth 3Y33.42%
OM growth 5Y-6.38%
PM growth 3Y-16.13%
PM growth 5Y-7.86%
GM growth 3Y3.14%
GM growth 5Y-2.08%
ALCGM.PA Yearly Profit, Operating, Gross MarginsALCGM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALCGM.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALCGM is destroying value.
  • The number of shares outstanding for ALCGM has been increased compared to 1 year ago.
  • ALCGM has less shares outstanding than it did 5 years ago.
  • ALCGM has a better debt/assets ratio than last year.
ALCGM.PA Yearly Shares OutstandingALCGM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
ALCGM.PA Yearly Total Debt VS Total AssetsALCGM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of 1.29, we must say that ALCGM is in the distress zone and has some risk of bankruptcy.
  • ALCGM has a Altman-Z score of 1.29. This is comparable to the rest of the industry: ALCGM outperforms 45.45% of its industry peers.
  • The Debt to FCF ratio of ALCGM is 4.02, which is a neutral value as it means it would take ALCGM, 4.02 years of fcf income to pay off all of its debts.
  • ALCGM's Debt to FCF ratio of 4.02 is fine compared to the rest of the industry. ALCGM outperforms 63.64% of its industry peers.
  • ALCGM has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
  • ALCGM has a Debt to Equity ratio of 1.07. This is comparable to the rest of the industry: ALCGM outperforms 45.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 4.02
Altman-Z 1.29
ROIC/WACC0.81
WACC5.2%
ALCGM.PA Yearly LT Debt VS Equity VS FCFALCGM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 0.99 indicates that ALCGM may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.99, ALCGM is doing worse than 63.64% of the companies in the same industry.
  • A Quick Ratio of 0.98 indicates that ALCGM may have some problems paying its short term obligations.
  • The Quick ratio of ALCGM (0.98) is worse than 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.98
ALCGM.PA Yearly Current Assets VS Current LiabilitesALCGM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ALCGM.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 163.69% over the past year.
  • The Earnings Per Share has been decreasing by -2.70% on average over the past years.
  • ALCGM shows a decrease in Revenue. In the last year, the revenue decreased by -0.81%.
  • Measured over the past years, ALCGM shows a small growth in Revenue. The Revenue has been growing by 5.49% on average per year.
EPS 1Y (TTM)163.69%
EPS 3Y-11.85%
EPS 5Y-2.7%
EPS Q2Q%153.38%
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y5.35%
Revenue growth 5Y5.49%
Sales Q2Q%-2.63%

3.2 Future

  • Based on estimates for the next years, ALCGM will show a very strong growth in Earnings Per Share. The EPS will grow by 32.74% on average per year.
  • Based on estimates for the next years, ALCGM will show a small growth in Revenue. The Revenue will grow by 2.80% on average per year.
EPS Next Y40%
EPS Next 2Y32.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.64%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALCGM.PA Yearly Revenue VS EstimatesALCGM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
ALCGM.PA Yearly EPS VS EstimatesALCGM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

8

4. ALCGM.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 20.15, ALCGM is valued on the expensive side.
  • Based on the Price/Earnings ratio, ALCGM is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, ALCGM is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 8.03 indicates a reasonable valuation of ALCGM.
  • Based on the Price/Forward Earnings ratio, ALCGM is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 23.68. ALCGM is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 20.15
Fwd PE 8.03
ALCGM.PA Price Earnings VS Forward Price EarningsALCGM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALCGM is valued cheaper than 100.00% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALCGM indicates a rather cheap valuation: ALCGM is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.47
EV/EBITDA 3.03
ALCGM.PA Per share dataALCGM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • ALCGM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ALCGM's earnings are expected to grow with 32.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y32.74%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALCGM.PA Dividend Analysis

5.1 Amount

  • ALCGM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALCGM.PA Fundamentals: All Metrics, Ratios and Statistics

CEGEDIM SA

EPA:ALCGM (4/9/2026, 7:00:00 PM)

13.7

+0.45 (+3.4%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-26
Earnings (Next)04-23
Inst Owners14.12%
Inst Owner ChangeN/A
Ins Owners58.96%
Ins Owner ChangeN/A
Market Cap193.17M
Revenue(TTM)649.17M
Net Income(TTM)9.40M
Analysts44.44
Price Target12.92 (-5.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.25%
Valuation
Industry RankSector Rank
PE 20.15
Fwd PE 8.03
P/S 0.3
P/FCF 2.47
P/OCF 1.27
P/B 0.68
P/tB N/A
EV/EBITDA 3.03
EPS(TTM)0.68
EY4.96%
EPS(NY)1.71
Fwd EY12.46%
FCF(TTM)5.55
FCFY40.51%
OCF(TTM)10.79
OCFY78.79%
SpS46.04
BVpS20.01
TBVpS-9.6
PEG (NY)0.5
PEG (5Y)N/A
Graham Number17.5
Profitability
Industry RankSector Rank
ROA 0.93%
ROE 3.33%
ROCE 5.75%
ROIC 4.23%
ROICexc 4.95%
ROICexgc 21.18%
OM 5.64%
PM (TTM) 1.45%
GM 20.78%
FCFM 12.05%
ROA(3y)-0.45%
ROA(5y)0.69%
ROE(3y)-1.64%
ROE(5y)2.23%
ROIC(3y)3.75%
ROIC(5y)3.59%
ROICexc(3y)4.19%
ROICexc(5y)3.94%
ROICexgc(3y)16.66%
ROICexgc(5y)15.03%
ROCE(3y)5.1%
ROCE(5y)4.89%
ROICexgc growth 3Y51.89%
ROICexgc growth 5Y-1.07%
ROICexc growth 3Y40.78%
ROICexc growth 5Y-3.81%
OM growth 3Y33.42%
OM growth 5Y-6.38%
PM growth 3Y-16.13%
PM growth 5Y-7.86%
GM growth 3Y3.14%
GM growth 5Y-2.08%
F-Score6
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 4.02
Debt/EBITDA 2.23
Cap/Depr 75.18%
Cap/Sales 11.39%
Interest Coverage 3.19
Cash Conversion 112.74%
Profit Quality 832.68%
Current Ratio 0.99
Quick Ratio 0.98
Altman-Z 1.29
F-Score6
WACC5.2%
ROIC/WACC0.81
Cap/Depr(3y)87.08%
Cap/Depr(5y)90.68%
Cap/Sales(3y)12.46%
Cap/Sales(5y)12.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)163.69%
EPS 3Y-11.85%
EPS 5Y-2.7%
EPS Q2Q%153.38%
EPS Next Y40%
EPS Next 2Y32.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.81%
Revenue growth 3Y5.35%
Revenue growth 5Y5.49%
Sales Q2Q%-2.63%
Revenue Next Year2.64%
Revenue Next 2Y2.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.62%
EBIT growth 3Y40.56%
EBIT growth 5Y-1.24%
EBIT Next Year264.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y555.84%
FCF growth 3Y96.33%
FCF growth 5Y16.9%
OCF growth 1Y49.43%
OCF growth 3Y20.74%
OCF growth 5Y6.64%

CEGEDIM SA / ALCGM.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CEGEDIM SA (ALCGM.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALCGM.PA.


What is the valuation status for ALCGM stock?

ChartMill assigns a valuation rating of 8 / 10 to CEGEDIM SA (ALCGM.PA). This can be considered as Undervalued.


What is the profitability of ALCGM stock?

CEGEDIM SA (ALCGM.PA) has a profitability rating of 3 / 10.


How financially healthy is CEGEDIM SA?

The financial health rating of CEGEDIM SA (ALCGM.PA) is 3 / 10.


What is the expected EPS growth for CEGEDIM SA (ALCGM.PA) stock?

The Earnings per Share (EPS) of CEGEDIM SA (ALCGM.PA) is expected to grow by 40% in the next year.